The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> January 3, 2023

Interview with the Executive Chairman and Director: Aclarion Inc. (NASDAQ:ACON)

Thramann, Jeff
Jeff Thramann, M.D., is the Executive Chairman and Director at Aclarion Inc. He oversees strategic initiatives, capitalization, and governance at the company. Dr. Thramann is a serial entrepreneur who has founded consumer and medtech companies such as Auddia Inc. (NASDAQ:AUUD,) Lanx, LLC (sold to Biomet Inc. November 2013,) ProNerve, LLC. (sold to Waud Capital Partners 2012), and U.S. Radiosurgery (sold to Alliance Healthcare Services (NASDAQ:AIQ) April 2011.) Dr. Thramann is also an accomplished neurosurgeon who founded and was a senior partner of Boulder Neurosurgical Associates, a neurosurgical practice serving Boulder County, Colorado. Dr. Thramann is the named inventor on over 100 U.S. and international issued and pending patents. He completed his neurosurgical residency and complex spinal reconstruction fellowship at the Barrow Neurological Institute in Phoenix, Arizona, and is a graduate of Cornell University Medical College in New York City. He also earned his Bachelor of Science degree in electrical engineering management at the U. S. Military Academy in West Point, New York. Profile
Word count: 3,179

TWST: Let’s start with an introduction to your company. Can you tell us about its history, its origins and where you are today?

Mr. Thramann:

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc
CEO INTERVIEWS
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO)
Interview with the Co-Founder and CEO: Equillium Inc. (NASDAQ:EQ)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Electric Cars and AI Fuel Long-Term Electricity Demand
Separating the Real Winners and Losers in the AI Boom
Generating Dividend Yield That’s Not Correlated to Interest Rates
ANALYST INTERVIEWS
Robust M&A Activity Provides Tailwind to Biotech Sector
Seeking Out Game Changers in Re-Emerging Biotech Sector
Obesity Drugmakers Still a ‘Buy’ Despite Lofty Valuations
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy